MDGL MADRIGAL PHARMACEUTICALS INC
2026Q1 · CUSIP 558868105 · Sector: Healthcare & Biotech
Fading · Price holds, watch
Holders
376
Δ holders QoQ
-13
Breadth percentile
Top 89%
Whale holders
186
Δ whales
+7
Inst. holding value
$12.4B
New positions
62
Closed positions
75
Price momentum (1Q)
+7.2%
Put / Call
14/15
Breadth history (34 quarters)
Past Lit Events & Aftermath 8 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 15% | +7.2% | — |
| 2025Q3 | Top 5% | -21.1% | -7.2% |
| 2025Q1 | Top 5% | +30.6% | +90.4% |
| 2024Q4 | Top 19% | -14.5% | +11.7% |
| 2024Q1 | Top 5% | +16.7% | +31.1% |
| 2023Q1 | Top 4% | -37.4% | -41.8% |
| 2022Q4 | Top 6% | -6.3% | -39.1% |
| 2018Q2 | Top 2% | -39.7% | -43.7% |
Options Sentiment
Put holders
14
QoQ: 0
Call holders
15
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-13.49
EPS YoY
—
Revenue (TTM)
$1.1B
Revenue YoY
+256.8%
Net margin
-27.3%
ROE
-56.9%
Debt ratio
55.7%
FCF (TTM)
-$272M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.